Anti-Adhesion Products: Global Strategic Business Report

Global Anti-Adhesion Products Market to Reach $863.1 Million by 2030

The global market for Anti-Adhesion Products estimated at US$606.5 Million in the year 2022, is projected to reach a revised size of US$863.1 Million by 2030, growing at a CAGR of 4.5% over the analysis period 2022-2030. Synthetic, one of the segments analyzed in the report, is projected to record 5.4% CAGR and reach US$499.7 Million by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Natural segment is readjusted to a revised 3.4% CAGR for the next 8-year period.

The U.S. Market is Estimated at $165.2 Million, While China is Forecast to Grow at 7.7% CAGR

The Anti-Adhesion Products market in the U.S. is estimated at US$165.2 Million in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$185 Million by the year 2030 trailing a CAGR of 7.7% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 1.4% and 5% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 2.3% CAGR.

Select Competitors (Total 21 Featured) -

• Anika Therapeutics, Inc.
• Baxter International Inc.
• Ethicon Inc.
• FzioMed, Inc.
• Integra LifeSciences Holdings Corporation
• Magen OrthoMed Ltd.
• MAST Biosurgery AG
• Sanofi SA

What's New?

• Special coverage on Russia-Ukraine war; global inflation; easing of zero-Covid policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.
• Global competitiveness and key competitor percentage market shares
• Market presence across multiple geographies - Strong/Active/Niche/Trivial
• Online interactive peer-to-peer collaborative bespoke updates
• Access to digital archives and Research Platform
• Complimentary updates for one year